Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Net product revenues	$ 1,902	$ 0	$ 4,042	$ 0
Cost of product sales	319	0	870	0
Gross margin	1,583	0	3,172	0
Operating expenses:
Research and development	2,989	6,641	6,736	15,620
Selling, general and administrative	22,086	6,553	71,957	13,214
Total operating expenses	25,075	13,194	78,693	28,834
Loss from operations	(23,492)	(13,194)	(75,521)	(28,834)
Other (income) expense:
Interest income	(680)	(61)	(1,738)	(156)
Interest expense	2,361	0	6,855	862
Foreign currency (gains) losses	(8)	(35)	13	(66)
Net loss	(25,123)	(13,068)	(80,277)	(29,351)
Deemed dividend	0	4,105	0	11,255
Accretion to redemption value	0	19	0	1,093
Net loss attributable to common stockholders	$ (25,123)	$ (17,192)	$ (80,277)	$ (41,699)
Net loss per share of common stock
basic (in USD per share)	$ (0.61)	$ (4.23)	$ (2.04)	$ (10.25)
diluted (in USD per share)	$ (0.61)	$ (4.23)	$ (2.04)	$ (10.25)
Weighted average common shares outstanding
basic (in shares)	41,207,167	4,067,717	39,260,903	4,067,717
diluted (in shares)	41,207,167	4,067,717	39,260,903	4,067,717
Grant and other income
Other (income) expense:
Grant and other income	$ (42)	$ (30)	$ (374)	$ (123)